169 related articles for article (PubMed ID: 32933748)
1. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.
Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A
Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748
[TBL] [Abstract][Full Text] [Related]
2. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.
Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064
[TBL] [Abstract][Full Text] [Related]
3. Excess of the NF-ĸB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1- and chemokines-mediated mechanisms.
Kravtsova-Ivantsiv Y; Goldhirsh G; Ivantsiv A; Ben Itzhak O; Kwon YT; Pikarsky E; Ciechanover A
Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29823-29831. PubMed ID: 33168738
[TBL] [Abstract][Full Text] [Related]
4. KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.
Kravtsova-Ivantsiv Y; Shomer I; Cohen-Kaplan V; Snijder B; Superti-Furga G; Gonen H; Sommer T; Ziv T; Admon A; Naroditsky I; Jbara M; Brik A; Pikarsky E; Kwon YT; Doweck I; Ciechanover A
Cell; 2015 Apr; 161(2):333-47. PubMed ID: 25860612
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation.
Orian A; Whiteside S; Israël A; Stancovski I; Schwartz AL; Ciechanover A
J Biol Chem; 1995 Sep; 270(37):21707-14. PubMed ID: 7665588
[TBL] [Abstract][Full Text] [Related]
7. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
[TBL] [Abstract][Full Text] [Related]
8. Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain.
Orian A; Schwartz AL; Israël A; Whiteside S; Kahana C; Ciechanover A
Mol Cell Biol; 1999 May; 19(5):3664-73. PubMed ID: 10207090
[TBL] [Abstract][Full Text] [Related]
9. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner.
Moorthy AK; Savinova OV; Ho JQ; Wang VY; Vu D; Ghosh G
EMBO J; 2006 May; 25(9):1945-56. PubMed ID: 16619030
[TBL] [Abstract][Full Text] [Related]
10. A20 inhibits both the degradation and limited processing of the NF-κB p105 precursor: A novel additional layer to its regulator role.
Lapid D; Lahav-Baratz S; Cohen S
Biochem Biophys Res Commun; 2017 Nov; 493(1):52-57. PubMed ID: 28923245
[TBL] [Abstract][Full Text] [Related]
11. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-κB precursor.
Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
Adv Exp Med Biol; 2011; 691():95-106. PubMed ID: 21153313
[No Abstract] [Full Text] [Related]
12. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.
Belich MP; Salmerón A; Johnston LH; Ley SC
Nature; 1999 Jan; 397(6717):363-8. PubMed ID: 9950430
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.
Ciechanover A; Gonen H; Bercovich B; Cohen S; Fajerman I; Israël A; Mercurio F; Kahana C; Schwartz AL; Iwai K; Orian A
Biochimie; 2001; 83(3-4):341-9. PubMed ID: 11295495
[TBL] [Abstract][Full Text] [Related]
14. Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ ubiquitin-ligase binding domain.
Cohen S; Orian A; Ciechanover A
J Biol Chem; 2001 Jul; 276(29):26769-76. PubMed ID: 11350967
[TBL] [Abstract][Full Text] [Related]
15. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor.
Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
Mol Cell; 2009 Feb; 33(4):496-504. PubMed ID: 19250910
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin ligase TRUSS augments the expression of interleukin-10 via proteasomal processing of NF-κB1/p105 to NF-κB/p50.
Jamal A; Husein A; Bihari C; Kumar V
Cell Signal; 2020 Nov; 75():109766. PubMed ID: 32889079
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway.
Kikuchi H; Ozaki T; Furuya K; Hanamoto T; Nakanishi M; Yamamoto H; Yoshida K; Todo S; Nakagawara A
Oncogene; 2006 Dec; 25(58):7608-17. PubMed ID: 16953234
[TBL] [Abstract][Full Text] [Related]
18. Two distinct ubiquitin-dependent mechanisms are involved in NF-kappaB p105 proteolysis.
Cohen S; Lahav-Baratz S; Ciechanover A
Biochem Biophys Res Commun; 2006 Jun; 345(1):7-13. PubMed ID: 16678126
[TBL] [Abstract][Full Text] [Related]
19. Differential response of NF-kappa B1 p105 and NF-kappa B2 p100 to HTLV-I encoded Tax.
Watanabe M; Muramatsu M; Tsuboi A; Arai K
FEBS Lett; 1994 Apr; 342(2):115-8. PubMed ID: 8143861
[TBL] [Abstract][Full Text] [Related]
20. SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase.
Orian A; Gonen H; Bercovich B; Fajerman I; Eytan E; Israël A; Mercurio F; Iwai K; Schwartz AL; Ciechanover A
EMBO J; 2000 Jun; 19(11):2580-91. PubMed ID: 10835356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
